JBC GenomeOne product landing page

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brody, J. R.
Right arrow Articles by Pasternack, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brody, J. R.
Right arrow Articles by Pasternack, G. R.

J Biol Chem, Vol. 274, Issue 29, 20053-20055, July 16, 1999

COMMUNICATION
Identification of Sequences Required for Inhibition of Oncogene-mediated Transformation by pp32

Jonathan R. Brody, Shrihari S. Kadkol, Moushira A. Mahmoud, Johanna M. J. Rebel, and Gary R. Pasternack

From the Division of Molecular Pathology, Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Oncogenic potential in prostate cancer is modulated in part by alternative use of genes of the pp32 family. This family includes the tumor suppressor pp32, expressed in normal tissue, and the pro-oncogenic genes pp32r1 and pp32r2 that are found principally in neoplastic cells. At the protein level, pp32, pp32r1, and pp32r2 are approximately 90% identical, yet they subsume opposite functions. In this study, we identify the region of pp32 associated with the ability to inhibit oncogene-mediated transformation in a rat embryo fibroblast system, an in vitro correlate of tumor-suppressive activity. Deletion and truncation analysis define a region spanning pp32 amino acids 150-174 as absolutely required for inhibition of transformed foci elicited by RAS and MYC. Comparison of pp32 with the pp32r1 sequence by moving averages of sequence identity reveals divergence over this region; pp32r2 also differs in this region through truncation after pp32 amino acid 131. The deletion experiments and the experiments of nature therefore converge to demonstrate that tumor-suppressive functions of pp32 reside in amino acids 150-174. Identification of this minimal tumor-suppressive region should help elaborate the pathways and mechanisms through which pp32 family members exert their functions.

Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
 Protein Sci.Home page
T. Huyton and C. Wolberger
The crystal structure of the tumor suppressor protein pp32 (Anp32a): Structural insights into Anp32 family of proteins
Protein Sci., July 1, 2007; 16(7): 1308 - 1315.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. T. Schafer, A. B. Parrish, K. M. Wright, S. S. Margolis, J. R. Marks, M. Deshmukh, and S. Kornbluth
Enhanced Sensitivity to Cytochrome c-Induced Apoptosis Mediated by PHAPI in Breast Cancer Cells
Cancer Res., February 15, 2006; 66(4): 2210 - 2218.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
O. Adegbola and G. R. Pasternack
Phosphorylated Retinoblastoma Protein Complexes with pp32 and Inhibits pp32-mediated Apoptosis
J. Biol. Chem., April 22, 2005; 280(16): 15497 - 15502.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. A. Loven, R. E. Davis, C. D. Curtis, N. Muster, J. R. Yates, and A. M. Nardulli
A Novel Estrogen Receptor {alpha}-Associated Protein Alters Receptor-Deoxyribonucleic Acid Interactions and Represses Receptor-Mediated Transcription
Mol. Endocrinol., November 1, 2004; 18(11): 2649 - 2659.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L.-G. Yu, L. C. Packman, M. Weldon, J. Hamlett, and J. M. Rhodes
Protein Phosphatase 2A, a Negative Regulator of the ERK Signaling Pathway, Is Activated by Tyrosine Phosphorylation of Putative HLA Class II-associated Protein I (PHAPI)/pp32 in Response to the Antiproliferative Lectin, Jacalin
J. Biol. Chem., October 1, 2004; 279(40): 41377 - 41383.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. R. Brody, S. S. Kadkol, M. C. Hauer, F. Rajaii, J. Lee, and G. R. Pasternack
pp32 Reduction Induces Differentiation of TSU-Pr1 Cells
Am. J. Pathol., January 1, 2004; 164(1): 273 - 283.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
X. Jiang, H.-E. Kim, H. Shu, Y. Zhao, H. Zhang, J. Kofron, J. Donnelly, D. Burns, S.-c. Ng, S. Rosenberg, et al.
Distinctive Roles of PHAP Proteins and Prothymosin-alpha in a Death Regulatory Pathway
Science, January 10, 2003; 299(5604): 223 - 226.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S.-b. Seo, T. Macfarlan, P. McNamara, R. Hong, Y. Mukai, S. Heo, and D. Chakravarti
Regulation of Histone Acetylation and Transcription by Nuclear Protein pp32, a Subunit of the INHAT Complex
J. Biol. Chem., April 12, 2002; 277(16): 14005 - 14010.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
C. M. Brennan, I.-E. Gallouzi, and J. A. Steitz
Protein Ligands to HuR Modulate Its Interaction with Target mRNAs In Vivo
J. Cell Biol., September 25, 2000; 151(1): 1 - 14.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.